Combined Metabolic Activators Improve Cognitive Functions in Alzheimer’s Disease Patients: A Randomized, Double-Blinded, Placebo-Controlled Phase-II Trial Clinical, Alzheimer's Disease, Neurological HealthANAD StaffJanuary 26, 2023Neurological Health, Alzheimer's Disease